Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 8/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propene SCHEMBL10531877 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL10530384 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL4957928 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL10531728 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL10530371 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL628378 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL10531739 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Propene SCHEMBL6739183 | 1.00 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| Ethylene Glycol SCHEMBL8852703 | 0.92 | THRB (0.57) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL9515117 | 0.92 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036312-B2 | Non-aqueous topical compositions comprising a halogenated salicylanilide | UNION therapeutics A/S (DK) | 2024-07-16 | — | — | US | claimed |
| CN-112313577-B | Radiation curable composition for additive manufacturing | 斯特拉塔西斯公司 | 2024-07-09 | — | — | CN | claimed |
| US-20230407132-A1 | (METH)ACRYLATE-FUNCTIONAL RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | COVESTRO (NETHERLANDS) B.V. (NL) | 2023-12-21 | — | — | US | claimed |
| EP-4237175-A1 | (METH)ACRYLATE-FUNCTIONAL RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | Covestro (Netherlands) B.V. (NL) | 2023-09-06 | — | — | EP | claimed |
| US-11485818-B2 | Radiation curable compositions for additive fabrication | COVESTRO (NETHERLANDS) B.V. (NL) | 2022-11-01 | — | — | US | claimed |
| WO-2022090342-A1 | (METH)ACRYLATE-FUNCTIONAL RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | COVESTRO (NETHERLANDS) BV (NL) | 2022-05-05 | — | — | WO | claimed |
| US-20210238339-A1 | RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | STRATASYS INC. | 2021-08-05 | — | — | US | claimed |
| EP-3781987-A1 | RADIATION CURABLE COMPOSITIONS FOR ADDITIVE FABRICATION | DSM IP Assets B.V. (NL) | 2021-02-24 | — | — | EP | claimed |
| CN-112313577-A | Radiation curable compositions for additive manufacturing | 帝斯曼知识产权资产管理有限公司 | 2021-02-02 | — | — | CN | claimed |
| EP-3429691-B1 | NON-AQUEOUS TOPICAL COMPOSITIONS COMPRISING A HALOGENATED SALICYLANILIDE | UNION THERAPEUTICS AS (DK) | 2020-11-04 | — | — | EP | claimed |
| US-7906564-B2 | Self etch all purpose dental cement composition, method of manufacture, and method of use thereof | PENTRON CLINICAL TECHNOLOGIES, LLC (US) | 2011-03-15 | — | — | US | claimed |
| CN-101720239-A | Implant device release agent and method of use thereof | ENDO PHARMACEUTICALS SOLUTIONS | 2010-06-02 | — | — | CN | claimed |
| EP-2139533-A2 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | Endo Pharmaceuticals Solutions Inc. (US) | 2010-01-06 | — | — | EP | claimed |
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | INDEVUS PHARMACEUTICALS, INC. | 2008-12-18 | — | — | US | claimed |
| WO-2008134475-A2 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | ENDO PHARMACEUTICALS SOLUTIONS INC., 33 (US) | 2008-11-06 | — | — | WO | claimed |
| EP-1986588-A2 | SELF ETCH ALL PURPOSE DENTAL COMPOSITION | Pentron Clinical Technologies, LLC (US) | 2008-11-05 | — | — | EP | claimed |
| US-20080242761-A1 | One part acrylated monomer with aromatic carboxylic anhydride functionality, multifunctional acrylate resin, diluent monomer and curing system; one step restorative dentistry; self and light curable | JIA WEITAO | 2008-10-02 | — | — | US | claimed |
| WO-2007100569-A2 | SELF ETCH ALL PURPOSE DENTAL COMPOSITION | PENTRON CLINICAL TECHNOLOGIES LLC (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070197683-A1 | SELF ETCH ALL PURPOSE DENTAL COMPOSITIONS, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF | PENTRON CLINICAL TECHNOLOGIES, INC (US) | 2007-08-23 | — | — | US | claimed |
| US-20070197682-A1 | Self etch all purpose dental cement composition, method of manufacture, and method of use thereof | PENTRON CORPORATION | 2007-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197682-A1 | Self etch all purpose dental cement composition, method of manufacture, and method of use thereof | FHIT, COPE, ASH2L | THRB 3947/4885TSHR 4848/4885ALDH1A1 4447/4885 |
| US-20080311170-A1 | IMPLANT DEVICE RELEASE AGENTS AND METHODS OF USING SAME | PTGES, VDR, HPGDS | THRB 1368/4885TSHR 476/4885ALDH1A1 4813/4885 |
| US-12036312-B2 | Non-aqueous topical compositions comprising a halogenated salicylanilide | CUTA, PTPN21, ABL2 | THRB 4089/4885TSHR 3500/4885ALDH1A1 1402/4885 |
| US-20070197683-A1 | SELF ETCH ALL PURPOSE DENTAL COMPOSITIONS, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF | CAD, FHIT, ACR | THRB 1851/4885TSHR 4432/4885ALDH1A1 681/4885 |
| US-20080242761-A1 | One part acrylated monomer with aromatic carboxylic anhydride functionality, multifunctional acrylate resin, diluent monomer and curing system; one step restorative dentistry; self and light curable | CAD, TAS2R42, ACR | THRB 1701/4885TSHR 3760/4885ALDH1A1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.